SBI Life shares jumped on improved product mix and higher sales, despite lower profit from commissions and investment income.

• Value for New Business margin rose to 27.8%, showing improved profitability despite the GST impact and higher commissions paid.
• Annualised premium equivalent sales grew 10% to ₹59.5 billion, highlighting robust customer demand for varied insurance products.
• Analysts, including JP Morgan and Phillip Capita,l maintain “Buy” ratings with a median target price of ₹2,140, citing steady fundamentals.